Related Experiment Video
Updated: Jun 24, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
Abnormal brain iron homeostasis in human and animal prion disorders
Ajay Singh1, Alfred Orina Isaac, Xiu Luo
1Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.
Abstract:
Neurotoxicity in all prion disorders is believed to result from the accumulation of PrP-scrapie (PrP(Sc)), a beta-sheet rich isoform of a normal cell-surface glycoprotein, the prion protein (PrP(C)). Limited reports suggest imbalance of brain iron homeostasis as a significant associated cause of neurotoxicity in prion-infected cell and mouse models. However, systematic studies on the generality of this phenomenon and the underlying mechanism(s) leading to iron dyshomeostasis in diseased brains are lacking. In this report, we demonstrate that prion disease-affected human, hamster, and mouse brains show increased total and redox-active Fe (II) iron, and a paradoxical increase in major iron uptake proteins transferrin (Tf) and transferrin receptor (TfR) at the end stage of disease. Furthermore, examination of scrapie-inoculated hamster brains at different timepoints following infection shows increased levels of Tf with time, suggesting increasing iron deficiency with disease progression. Sporadic Creutzfeldt-Jakob disease (sCJD)-affected human brains show a similar increase in total iron and a direct correlation between PrP and Tf levels, implicating PrP(Sc) as the underlying cause of iron deficiency. Increased binding of Tf to the cerebellar Purkinje cell neurons of sCJD brains further indicates upregulation of TfR and a phenotype of neuronal iron deficiency in diseased brains despite increased iron levels. The likely cause of this phenotype is sequestration of iron in brain ferritin that becomes detergent-insoluble in PrP(Sc)-infected cell lines and sCJD brain homogenates. These results suggest that sequestration of iron in PrP(Sc)-ferritin complexes induces a state of iron bio-insufficiency in prion disease-affected brains, resulting in increased uptake and a state of iron dyshomeostasis. An additional unexpected observation is the resistance of Tf to digestion by proteinase-K, providing a reliable marker for iron levels in postmortem human brains. These data implicate redox-iron in prion disease-associated neurotoxicity, a novel observation with significant implications for prion disease pathogenesis.
Insights
Prion diseases cause neurotoxicity by sequestering iron in brain ferritin, leading to iron deficiency and neurotoxicity. This iron dyshomeostasis is linked to prion protein accumulation and offers new therapeutic targets.
Area of Science:
- Neuroscience
- Biochemistry
- Prion Disease Research
Background:
- Prion diseases, including Creutzfeldt-Jakob disease (CJD), are linked to neurotoxicity from abnormal prion protein (PrPSc) accumulation.
- Previous studies suggest brain iron dyshomeostasis may contribute to neurotoxicity in prion diseases, but mechanisms remain unclear.
Purpose of the Study:
- To investigate the role of iron homeostasis in prion disease neurotoxicity across species.
- To elucidate the mechanisms underlying iron dysregulation in prion-affected brains.
Main Methods:
- Analysis of iron levels and iron-related proteins (transferrin, transferrin receptor, ferritin) in human, hamster, and mouse brains affected by prion disease.
- Time-course studies in scrapie-infected hamsters.
- Investigation of ferritin insolubility in prion-infected cell lines and human sCJD brain homogenates.
- Assessment of transferrin resistance to proteinase-K digestion.
Main Results:
- Prion disease brains exhibit increased total and redox-active iron, alongside elevated transferrin and transferrin receptor levels.
- Iron deficiency is suggested by increasing transferrin levels with disease progression in hamsters.
- Sporadic CJD brains show a correlation between PrPSc and transferrin, indicating PrPSc causes iron deficiency.
- Neuronal iron deficiency is observed despite increased brain iron, due to iron sequestration in detergent-insoluble ferritin complexes.
- Transferrin demonstrated resistance to proteinase-K digestion, serving as a potential postmortem biomarker.
Conclusions:
- Iron sequestration in PrPSc-ferritin complexes induces bio-insufficient iron states and dyshomeostasis in prion diseases.
- Redox-active iron and iron dyshomeostasis are implicated in prion disease-associated neurotoxicity.
- Transferrin's resistance to proteinase-K offers a novel method for assessing postmortem brain iron levels.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Hepatic Encephalopathy
Neural Regulation
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology

